Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Urovant Sciences Ltd. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsMar-31-19Mar-31-18Mar-31-17
Revenues0.00.026.1
            Revenue growth -100.0% 
Cost of goods sold0.00.00.0
Gross profit0.00.026.1
            Gross margin  100.0%
Selling, general and administrative  27.1
Research and development92.232.4 
General and administrative18.64.6 
EBIT-110.8-37.0-0.9
            EBIT margin  -3.5%
Pre-tax income-111.3-37.0-27.0
Income taxes0.00.00.0
            Tax rate  0.0%
Net income-111.3-37.1-27.0
            Net margin  -103.2%
 
Diluted EPS($4.43)($2.16)($10.10)
Shares outstanding (diluted)25.117.12.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy